A61K 31/77
Of oxiranes
Official title: of oxiranes
A61K31/77 (Of oxiranes) appears on 258 US grants and 334 published applications in this corpus.
Search patents in A61K- Granted patents
- 258
- Published applications
- 334
- Assignees
- 220
- Inventors
- 663
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 7 | 0 |
| 1997 | 10 | 0 |
| 1998 | 9 | 0 |
| 1999 | 4 | 0 |
| 2000 | 8 | 0 |
| 2001 | 4 | 2 |
| 2002 | 5 | 11 |
| 2003 | 4 | 12 |
| 2004 | 5 | 10 |
| 2005 | 4 | 6 |
| 2006 | 5 | 2 |
| 2007 | 2 | 4 |
| 2008 | 0 | 8 |
| 2009 | 1 | 14 |
| 2010 | 9 | 22 |
| 2011 | 2 | 11 |
| 2012 | 3 | 11 |
| 2013 | 11 | 17 |
| 2014 | 10 | 24 |
| 2015 | 13 | 21 |
| 2016 | 10 | 23 |
| 2017 | 13 | 27 |
| 2018 | 13 | 13 |
| 2019 | 12 | 10 |
| 2020 | 12 | 20 |
| 2021 | 7 | 12 |
| 2022 | 9 | 11 |
| 2023 | 9 | 16 |
| 2024 | 5 | 13 |
| 2025 | 12 | 7 |
| 2026 | 6 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Surface treatment of contact lens and treatment of ocular discomfort by water soluble polymers and lipids/liposomes22 Sep 2026US 12,740,942 B2Yeda Research and Development Co. Ltd.
- Crosslinkable prepolymers for chemically stable polymer gels14 Apr 2026US 12,600,808 B2Odne AG
- Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury7 Apr 2026US 12,594,297 B2Medicrinia, Co., Ltd.
- Methods of administering safe colon cleansing compositions7 Apr 2026US 12,594,298 B2Azurity Pharmaceuticals, Inc.
- Therapy to stimulate hippocampal neural progenitors and adult neurogenesis31 Mar 2026US 12,589,109 B2University of Notre Dame du Lac
- Amphiphilic nanoparticles to target amyloid beta-induced microglial activation10 Sep 2026US 2026/0263373 A1Rutgers, The State University of New Jersey
- Effervescent Laxative Composition30 Apr 2026US 2026/0115225 A1L. Perrigo Company
- Methods and compositions for prevention and treatment of acute radiation syndromes (ars)30 Apr 2026US 2026/0115293 A1Maroon Biotech Corporation
- Adjuvants for enhancing the immune response16 Apr 2026US 2026/0102484 A1Lankenau Institute for Medical Research
- Metap2 inhibitors and methods of treating obesity19 Mar 2026US 2026/0076960 A1SynDevRx, Inc.
Most cited
By later US patents
- Methods and compositions for reducing or eliminating post-surgical adhesion formation207US 6,136,333 ALife Medical Sciences, Inc. · 2000
- Methods for reducing or eliminating post-surgical adhesion formation203US 5,711,958 ALife Medical Sciences, Inc. · 1998
- High molecular weight polymer-based prodrugs182US 5,614,549 AEnzon, Inc. · 1997
- Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides169US 5,126,141 AMediventures, Inc. · 1992
- Injectable medical composition and method of use119US 5,639,796 AC. R. Bard, Inc. · 1997